Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...

The number of psychiatrists submitting more than 10 claims to Medicare Part B decreased by 16.8% from 2014 to 2022.

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated ...

Panelists discuss how employers optimize biosimilar uptake through strategic formulary design, financial incentives, and provider education, enabling health care systems to achieve substantial cost ...

Panelists discuss how biosimilars have significantly reduced health care costs in the US, with health care systems experiencing significant savings across various therapeutic areas. These cost ...

Greater pain intensity in cancer survivors correlates with increased cigarette, e-cigarette, and cannabis use, but decreased alcohol consumption. Greater pain intensity in cancer survivors has been ...

An expert discusses how recent trials address the unmet needs of UTI patients and highlights key areas where further research and collaboration are essential for improving patient outcomes.

An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase-phenotype Gram ...

Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals ...